PE20010167A1 - Amidas de acidos fenilciclohexanocarboxilicos sustituidos con actividad inhibidora de la incorporacion de adenosina - Google Patents

Amidas de acidos fenilciclohexanocarboxilicos sustituidos con actividad inhibidora de la incorporacion de adenosina

Info

Publication number
PE20010167A1
PE20010167A1 PE2000000506A PE0005062000A PE20010167A1 PE 20010167 A1 PE20010167 A1 PE 20010167A1 PE 2000000506 A PE2000000506 A PE 2000000506A PE 0005062000 A PE0005062000 A PE 0005062000A PE 20010167 A1 PE20010167 A1 PE 20010167A1
Authority
PE
Peru
Prior art keywords
phenyl
alkyl
cycloalkyl
adenosine
incorporation
Prior art date
Application number
PE2000000506A
Other languages
English (en)
Inventor
Joachim Schuhmacher
Holger Paulsen
Stephan Nicholas Muller
Stephen Lensky
Ervin Horvath
Wolf-Dietrich Freund
Jorg Keldenich
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PE20010167A1 publication Critical patent/PE20010167A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE REFIERE A COMPUESTOS DE AMIDAS DE ACIDOS FENILCICLOHEXANOCARBOXILICOS SUSTITUIDOS DE FORMULA I DONDE A, D, E, G SON CH, N; L1 Y L2 SON H, HALOGENO, OH, CARBOXILO, CIANO, NITRO, ENTRE OTROS; R1 ES CH2-OH, CO-NR4R5; R4 Y R5 SON H, ALQUILO C1-C6; R2 ES CICLOALQUILO C3-C8, ALQUILO C1-C8, HETEROCICLO DE 4-8 MIEMBROS UNIDO A UN IMIDAZOL, HETEROCICLO DE 4-8 MIEMBROS CON NR7, N, O, S, CICLOALQUILO C3-C8, ALQUILO C1-C8, ENTRE OTROS; R6 Y R7 SON H, ALQUILO C1-C6, HIDROXIALQUILO C1-C6, CICLOALQUILO C3-C7; R8 Y R9 SON H, ALQUILO C1-C6, CICLOALQUILO C3-C7, JUNTO CON N FORMAN UN HETEROCICLO DE 4 A 8 MIEMBROS; R3 ES FENILO, NAFTILO, PIRIMIDINILO, PIRIDILO, FURILO, TIENILO, ENTRE OTROS. UN COMPUESTO PREFERIDO ES (S)-N-{{(1R,2R)-2-{4-{[2-(4-METIL-PIPERAZIN-1-IL)-BENCIMIDAZOL-1-IL]METIL}-FENIL}-CICLOHEX-1-IL}CARBONIL}-FENILGLICINAMIDA. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION Y A COMPUESTOS INTERMEDIOS. LOS COMPUESTOS DE FORMULA I TIENEN ACTIVIDAD INHIBIDORA DE LA INCORPORACION DE ADENOSINA Y PUEDEN SER UTILES PARA EL TRATAMIENTO DE ISQUEMICAS CEREBRALES, TRAUMA CEREBRAL
PE2000000506A 1999-05-29 2000-05-26 Amidas de acidos fenilciclohexanocarboxilicos sustituidos con actividad inhibidora de la incorporacion de adenosina PE20010167A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19924818A DE19924818A1 (de) 1999-05-29 1999-05-29 Substituierte Phenylcyclohexancarbonsäureamide

Publications (1)

Publication Number Publication Date
PE20010167A1 true PE20010167A1 (es) 2001-04-25

Family

ID=7909712

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000506A PE20010167A1 (es) 1999-05-29 2000-05-26 Amidas de acidos fenilciclohexanocarboxilicos sustituidos con actividad inhibidora de la incorporacion de adenosina

Country Status (36)

Country Link
US (2) US6716849B1 (es)
EP (1) EP1185516B1 (es)
JP (1) JP2003500475A (es)
KR (1) KR20020003397A (es)
CN (1) CN1200932C (es)
AR (1) AR024100A1 (es)
AT (1) ATE238997T1 (es)
AU (1) AU765752B2 (es)
BG (1) BG106107A (es)
BR (1) BR0011061A (es)
CA (1) CA2375186A1 (es)
CZ (1) CZ20014288A3 (es)
DE (2) DE19924818A1 (es)
DK (1) DK1185516T3 (es)
EE (1) EE200100634A (es)
ES (1) ES2197870T3 (es)
GT (1) GT200000083A (es)
HK (1) HK1048810A1 (es)
HN (1) HN2000000072A (es)
HR (1) HRP20010955A2 (es)
HU (1) HUP0201350A3 (es)
IL (1) IL146392A0 (es)
MA (1) MA25414A1 (es)
MX (1) MXPA01012241A (es)
MY (1) MY122576A (es)
NO (1) NO20015810L (es)
PE (1) PE20010167A1 (es)
PL (1) PL352101A1 (es)
PT (1) PT1185516E (es)
RU (1) RU2246490C9 (es)
SI (1) SI1185516T1 (es)
SK (1) SK17052001A3 (es)
SV (1) SV2004000087A (es)
UA (1) UA73126C2 (es)
WO (1) WO2000073275A1 (es)
ZA (1) ZA200109263B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1834090B (zh) * 2005-03-18 2011-06-29 中国科学院上海药物研究所 苯并咪唑类化合物、其制备方法以及用途
AR072143A1 (es) * 2008-06-16 2010-08-11 Boehringer Ingelheim Int Procedimiento para la preparacion de un producto intermedio para la sintesis de etexilato de dabigatran
EP2858983B1 (en) 2012-06-11 2018-04-18 UCB Biopharma SPRL Tnf-alpha modulating benzimidazoles
WO2020107013A1 (en) * 2018-11-25 2020-05-28 Bluevalley Pharmaceutical Llc Orally active prodrug of gemcitabine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2685918B1 (fr) 1992-01-08 1995-06-23 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
DE4221009A1 (de) 1992-06-26 1994-01-05 Bayer Ag Imidazolyl-substituierte Cyclohexanderivate
ES2125285T3 (es) * 1992-07-31 1999-03-01 Bristol Myers Squibb Co Derivados inhibidores de la reabsorcion de adenosina de difenil-oxazoles, tiazoles e imidazoles.
DE4304455A1 (de) 1993-02-15 1994-08-18 Bayer Ag Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate
DE4401893A1 (de) 1994-01-24 1995-07-27 Bayer Ag Substituierte Arylharnstoffe
HRP960015B1 (en) 1995-02-01 2000-12-31 Bayer Ag Substituted indole derivatives
DE19503160A1 (de) 1995-02-01 1996-08-08 Bayer Ag Verwendung von Phenylcyclohexylcarbonsäureamiden

Also Published As

Publication number Publication date
EP1185516B1 (de) 2003-05-02
DK1185516T3 (da) 2003-08-11
PL352101A1 (en) 2003-07-28
PT1185516E (pt) 2003-09-30
SK17052001A3 (sk) 2002-06-04
NO20015810L (no) 2002-01-25
UA73126C2 (en) 2005-06-15
CZ20014288A3 (cs) 2002-03-13
ES2197870T3 (es) 2004-01-16
MY122576A (en) 2006-04-29
HUP0201350A2 (en) 2002-08-28
HK1048810A1 (zh) 2003-04-17
HN2000000072A (es) 2001-02-02
SV2004000087A (es) 2004-05-07
MA25414A1 (fr) 2002-04-01
CA2375186A1 (en) 2000-12-07
DE19924818A1 (de) 2000-11-30
ATE238997T1 (de) 2003-05-15
ZA200109263B (en) 2003-01-29
RU2246490C2 (ru) 2005-02-20
US20040186106A1 (en) 2004-09-23
IL146392A0 (en) 2002-07-25
EP1185516A1 (de) 2002-03-13
RU2246490C9 (ru) 2005-09-20
AU4405500A (en) 2000-12-18
BG106107A (bg) 2002-05-31
EE200100634A (et) 2003-02-17
BR0011061A (pt) 2002-03-05
KR20020003397A (ko) 2002-01-12
HUP0201350A3 (en) 2003-05-28
GT200000083A (es) 2001-11-17
AU765752B2 (en) 2003-09-25
AR024100A1 (es) 2002-09-04
DE50001982D1 (de) 2003-06-05
CN1200932C (zh) 2005-05-11
CN1365356A (zh) 2002-08-21
NO20015810D0 (no) 2001-11-28
WO2000073275A1 (de) 2000-12-07
HRP20010955A2 (en) 2003-08-31
JP2003500475A (ja) 2003-01-07
MXPA01012241A (es) 2002-08-12
SI1185516T1 (en) 2003-10-31
US6716849B1 (en) 2004-04-06

Similar Documents

Publication Publication Date Title
NO933452D0 (no) Et terapeutisk middel for parkinson's sykdom
RU98108027A (ru) Производные имидазола, обладающие аффинностью в отношении активности альфа2- рецепторов
AR048361A1 (es) Derivados de tetrahidroquinolina y un procedimiento para preparar los mismos
PE58699A1 (es) Derivados de acido arilsulfonil hidroxamico
PE20060693A1 (es) Nuevos derivados de trifluorometansulfonanilida oxamida eter
RU2008127257A (ru) Тризамещенные производные хиназолинона в качестве ваниллоидных антагонистов
RU2004117543A (ru) Амиды антраниловой кислоты и их применение в качестве ингибиторов тирозинкиназного рецептора фактора роста сосудистого эндотелия (vegf)
KR880007461A (ko) 헤테로 사이클-치환 디포스포네이트화합물 및 이의 약제학적 조성물
ES2138594T3 (es) Agentes derivados de piridina e imidazol para enfermedades cardiovasculares.
PE20050160A1 (es) 3-aminopirrolidinas como inhibidores de la captacion de monoaminas
PE20010167A1 (es) Amidas de acidos fenilciclohexanocarboxilicos sustituidos con actividad inhibidora de la incorporacion de adenosina
KR900012893A (ko) 치환된-아세트 아미드 화합물 및 그 제조방법
HU911992D0 (en) 2-(amino-alkyl)-5-(aryl-alkyl)-1,3-dioxanes, and process for the production of the medical preparations containing them
ATE161178T1 (de) Pyrazolpyridine für die behandlung der anämie
PE20010132A1 (es) Amidas sustituidas del acido fenilciclohexanocarboxilico y su uso como inhibidores de la incorporacion de adenosina
DK1335928T3 (da) Selektive glukokortikoidreceptoragonister
KR900014339A (ko) 헤테로시클릭 화합물, 그의 제조방법, 이를 함유하는 제약 조성물 및 의약으로서의 용도
GB9402016D0 (en) Therapeutic agents
KR920703577A (ko) 치환된 이환식 화합물의 이미다졸-2-일 유도체 및 이의 제조방법
RU96123896A (ru) Производные амидов кислот и способ их получения
RU2001120005A (ru) Производные амидов и мочевины в качестве ингибиторов вторичного поглощения 5-HT и лигандов 5-HT1B/1D

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed